MONICA PFEIFFER: Open Payments
NPI 1770918526 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,865 in 97 payments from 20 companies in 2025. Trend: 2023 $1,423 · 2024 $1,700 · 2025 $1,865
Food & beverage: $1,865
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $341 |
| AstraZeneca Pharmaceuticals LP | 12 | $289 |
| ABBVIE INC. | 13 | $236 |
| PFIZER INC. | 12 | $194 |
| GlaxoSmithKline, LLC. | 12 | $148 |
| Abbott Laboratories | 6 | $120 |
| Lilly USA, LLC | 4 | $87 |
| Amgen Inc. | 5 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $57 |
Products named: AIRSUPRA, Wegovy, QULIPTA, Ozempic, SHINGRIX, FREESTYLE LIBRE 3, ELIQUIS, UBRELVY.
Industry payments across KS — which companies pay providers there.
